Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accelerated BEP Chemotherapy for Intermediate and High Risk Metastatic Germ Cell Tumor

NCT00453232 is registered in ClinicalTrials.gov with Cambridge University Hospitals NHS Foundation Trust as lead sponsor.

NCT NCT00453232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00453232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accelerated BEP Chemotherapy for Intermediate and High Risk Metastatic Germ Cell Tumor
Lead sponsor
Cambridge University Hospitals NHS Foundation Trust
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2004
Completion date
January 31, 2009
Enrollment
20 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

extragonadal germ cell tumor, teratoma, testicular germ cell tumor